PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVG.L Share News (EVG)

  • There is currently no data for EVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks fall after flat start

Fri, 09th Sep 2011 12:06

Stocks have eased slightly as nerves set in ahead of this weekend's meeting of the G7 grouping of industrialised countries.Motor insurer Admiral is in the slow lane after saying it could see "a small proportion" of its profits put at risk under the government's plans to ban the payment of referral fees to insurers. The Ministry of Justice (MoJ) announced that it plans to tackle rising insurance costs by placing abolishing the fees, as part of its commitment to curb 'compensation culture'. Referral fees account for 6% of Admiral's UK car insurance profit before tax.But Tullow Oil gushed higher after a joint venture it operates made an oil discovery at its Zeadyus exploration well, 150km offshore French Guiana. Shares surged over 8% in the opening minutes after its chief executive said, "The discovery at Zaedyus has proved the extension of the Jubilee-play across the Atlantic and made an important new discovery in French Guiana."Tullow owns 27.5% of the licence. North Petroleum and Wessex Exploration, which own 50% each of a joint venture with a 2.5% interest in the licence, have gushed higher. Shares of Investec edged higher after its announcement of a recommended offer for Evolution Securities, valuing the investment banking and stockbroking firm at £233.2m. Evolution's shares were given a boost early on.FTSE 250 oil and gas group Salamander Energy fell into the red after increasing its stake in Block G4/50, one of the largest blocks of prospective acreage in the Gulf of Thailand.Pubs group JD Wetherspoon saw shares drop after announcing that while like-for-like sales grew by 2.1% in the year to 24 July, the growth rate has slowed to 0.4% in the six weeks to 4 September.Multi-metal mining colossus Rio Tinto was lower after saying that it is to invest $310m to assure a sustainable water supply for its iron ore operations in Pilbara, Western Australia.FTSE 100 - RisersTullow Oil (TLW) 1,391.00p +13.37%Fresnillo (FRES) 2,194.00p +2.19%Imperial Tobacco Group (IMT) 2,096.00p +1.75%British Sky Broadcasting Group (BSY) 677.00p +1.20%Severn Trent (SVT) 1,472.00p +0.82%British Land Co (BLND) 525.00p +0.77%Next (NXT) 2,361.00p +0.55%British American Tobacco (BATS) 2,776.00p +0.49%Petrofac Ltd. (PFC) 1,391.00p +0.43%Morrison (Wm) Supermarkets (MRW) 302.80p +0.40%FTSE 100 - FallersLloyds Banking Group (LLOY) 30.99p -5.81%Royal Bank of Scotland Group (RBS) 21.58p -5.10%Admiral Group (ADM) 1,295.00p -5.06%Barclays (BARC) 151.50p -4.72%Xstrata (XTA) 1,006.00p -4.10%Glencore International (GLEN) 420.15p -3.75%International Consolidated Airlines Group SA (IAG) 156.40p -3.58%Vedanta Resources (VED) 1,402.00p -3.38%Aviva (AV.) 310.80p -3.12%GKN (GKN) 182.60p -2.98%FTSE 250 - RisersExillon Energy (EXI) 262.00p +13.76%Ocado Group (OCDO) 116.20p +7.10%JKX Oil & Gas (JKX) 183.10p +6.45%Imagination Technologies Group (IMG) 360.30p +4.43%EnQuest (ENQ) 106.40p +4.42%Kofax (KFX) 307.00p +2.68%Pennon Group (PNN) 672.00p +2.60%Hansteen Holdings (HSTN) 79.00p +2.60%ITE Group (ITE) 183.10p +2.29%AZ Electronic Materials SA (WI) (AZEM) 240.00p +2.04%FTSE 250 - FallersHome Retail Group (HOME) 110.80p -5.94%Enterprise Inns (ETI) 32.41p -4.48%Debenhams (DEB) 53.30p -4.39%New World Resources A Shares (NWR) 582.00p -4.35%JD Wetherspoon (JDW) 399.30p -4.01%Yule Catto & Co (YULC) 173.00p -4.00%SThree (STHR) 230.70p -3.92%Cookson Group (CKSN) 446.00p -3.78%Inchcape (INCH) 283.90p -3.76%Ferrexpo (FXPO) 368.00p -3.72%
More News
22 Mar 2021 14:32

IN BRIEF: Evgen Pharma names Helen Kuhlman as chief business officer

IN BRIEF: Evgen Pharma names Helen Kuhlman as chief business officer

Read more
22 Mar 2021 09:08

Evgen appoints Helen Kuhlman as chief business officer

(Sharecast News) - Clinical-stage drug development company Evgen announced on Monday that Helen Kuhlman had been appointed to the post of chief business officer, taking up the role from 1 April.

Read more
11 Mar 2021 20:08

IN BRIEF: Evgen says no patient safety concerns in STAR Covid-19 trial

IN BRIEF: Evgen says no patient safety concerns in STAR Covid-19 trial

Read more
11 Mar 2021 15:12

Evgen Covid-19 trial given all-clear on safety and data

(Sharecast News) - Clinical stage drug development company Evgen Pharma announced on Thursday that after a review of the first 60 patients enrolled, the data safety monitoring committee for the 'STAR' Covid-19 trial had concluded that there were no concerns over patient safety or data quality that would prevent its continuation.

Read more
3 Mar 2021 20:16

TRADING UPDATES: Cambria drives on amid virus; Argo crypto mining up

TRADING UPDATES: Cambria drives on amid virus; Argo crypto mining up

Read more
24 Feb 2021 16:09

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
17 Feb 2021 15:10

Evgen makes progress with recruitment in 'STAR' trial

(Sharecast News) - Clinical stage drug development company Evgen Pharma said on Wednesday that a total of 102 patients had been recruited and randomised to the 'STAR', or 'SFX-01 Treatment for Acute Respiratory infections', trial.

Read more
17 Feb 2021 11:15

IN BRIEF: Evgen Pharma Recruits Over 100 For Respiratory Drug Trial

IN BRIEF: Evgen Pharma Recruits Over 100 For Respiratory Drug Trial

Read more
3 Feb 2021 11:49

IN BRIEF: Intuitive Investments Buys Shares in Evgen For GBP175,000

IN BRIEF: Intuitive Investments Buys Shares in Evgen For GBP175,000

Read more
2 Feb 2021 17:45

IN BRIEF: Evgen Pharma's GBP11 Fundraise To Support Lead Candidate

IN BRIEF: Evgen Pharma's GBP11 Fundraise To Support Lead Candidate

Read more
22 Jan 2021 08:53

Evgen Shares Rise On Further Positive Test Results For SFX-01

Evgen Shares Rise On Further Positive Test Results For SFX-01

Read more
21 Jan 2021 13:20

IN BRIEF: Evgen Pharma Notes Positive Preclinical Data For SFX-01

IN BRIEF: Evgen Pharma Notes Positive Preclinical Data For SFX-01

Read more
19 Jan 2021 17:34

IN BRIEF: Evgen Pharma Recruits Patients For STAR-Covid-19 Trial

IN BRIEF: Evgen Pharma Recruits Patients For STAR-Covid-19 Trial

Read more
10 Dec 2020 17:07

UK EARNINGS SUMMARY: Character Group Lowers Dividend As Profit Drops

UK EARNINGS SUMMARY: Character Group Lowers Dividend As Profit Drops

Read more
10 Dec 2020 15:45

Evgen Pharma performs in line with forecasts in first half

(Sharecast News) - Clinical-stage drug development company Evgen Pharma reported financial performance in line with its expectations in its first half on Thursday, with revenue coming in at £0.19m, compared to nil a year earlier.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.